[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369571-105":59,"doc-detail-369571-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-interplay-between-driver-mutation-and-oxidative-stress-in-colorectal-cancer-from-pathogenesis-to-therapeutics","The interplay between driver mutation and oxidative stress in colorectal cancer: from pathogenesis to therapeutics","","Colorectal cancer (CRC) is a complex disease shaped by genetic mutations and environmental influences, with oxidative stress emerging as a key mediator. Driver mutations guide CRC initiation and progression by rewiring signaling pathways that control proliferation, apoptosis, and genomic stability. Oxidative stress reflects an imbalance between reactive oxygen species (ROS) generation and antioxidant defenses, driving DNA damage, lipid peroxidation, and disrupted redox signaling. Understanding how driver mutations intersect with oxidative stress pathways clarifies their combined or antagonistic effects on CRC heterogeneity, treatment responses, and clinical outcomes. This review discusses these links, highlights emerging trends, and outlines future research directions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-interplay-between-driver-mutation-and-oxidative-stress-in-colorectal-cancer-from-pathogenesis-to-therapeutics/369571/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-interplay-between-driver-mutation-and-oxidative-stress-in-colorectal-cancer-from-pathogenesis-to-therapeutics/369571.png","ImageObject",300,407,{"name":92,"@type":93},"Fahsai","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How do driver mutations contribute to colorectal cancer development?","Question",{"text":112,"@type":113},"Driver mutations initiate and advance CRC by altering key signaling pathways that regulate cell proliferation, apoptosis, and genomic stability. These changes support tumor growth and therapeutic resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is oxidative stress and why is it important in CRC?",{"text":117,"@type":113},"Oxidative stress results from an imbalance between ROS production and antioxidant defenses. It promotes DNA damage, lipid peroxidation, and redox signaling dysregulation, influencing CRC pathogenesis.",{"name":119,"@type":110,"acceptedAnswer":120},"How does oxidative stress interact with therapeutic responses in CRC?",{"text":121,"@type":113},"Oxidative stress can act as both a tumorigenic factor and a modulator of therapeutic responses. ROS-induced damage and altered redox signaling can affect treatment outcomes and resistance mechanisms.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369571,1791672383,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","Huang et al. Journal of Translational Medicine (2025) 23:635  \n[https://doi.org/10.1186/s12967-025-06640-x](https://doi.org/10.1186/s12967-025-06640-x)  \nJournal of Translational Medicine  \n REVIEW Open Access  \nThe interplay between driver mutation and oxidative stress in colorectal cancer: from pathogenesis to therapeutics  \nQi Huang1†, Yuan Jing2†, Lihua Xiong3†, Lei Li4*, Jingjuan Feng5* and Jian Cheng5*  \nAbstract  \nColorectal cancer (CRC) is a multifaceted disease influenced by genetic mutations and environmental factors, especially oxidative stress. Driver mutations are pivotal in CRC initiation and progression and alter key signaling pathways involved in cell proliferation, apoptosis, and genomic stability. Concurrently, oxidative stress, characterized by an imbalance between reactive oxygen species (ROS) production and antioxidant defenses, plays a crucial role in CRC development by promoting DNA damage, lipid peroxidation, and redox signaling dysregulation. The molecular mechanisms linking driver mutations and oxidative stress pathways underscore their collective or antagonistic impact on CRC heterogeneity, therapeutic responses, and clinical outcomes. Insights into mutation-specific vulnerabilities and redox modulation offer promising avenues for targeted therapies and personalized medicine approaches in CRC treatment. Here, we discuss the intricate interplay between driver mutations and oxidative stress, highlight emerging trends, and propose future research directions to advance our understanding of CRC pathogenesis and optimize therapeutic interventions.  \nKeywords Driver mutation, Colorectal cancer, Oxidative stress, Therapeutic resistance, Epigenetic modification  \n†Qi Huang, Yuan Jing, and Lihua Xiong contributed equally to this work.  \n*Correspondence: Lei Li [leileo828@163.com](leileo828@163.com)[ ](leileo828@163.com)Jingjuan Feng [fengjjsc@163.com](fengjjsc@163.com)[ ](fengjjsc@163.com)Jian Cheng  \n[chengjian@med.uestc.edu.cn](chengjian@med.uestc.edu.cn)  \n1 Department of Anorectal Surgery, The People’s Hospital of Leshan, Leshan 614000, China  \n2 Department of Medical Records, The People’s Hospital of Leshan, Leshan 614000, China  \n3 Department of Dermatology, Cheng Du Xinjin District Hospital of Traditional Chinese Medicine, Chengdu 610500, China  \n4 Department of Anorectal Surgery, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China  \n5 Department of Traditional Chinese Medicine, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China  \nIntroduction  \nColorectal cancer (CRC) remains a significant global health challenge and is responsible for substantial morbidity and mortality worldwide [1, 2]. CRC arises from a complex interplay of genetic mutations, environmental factors, and lifestyle influences, highlighting its heterogeneous and multifaceted nature [3]. Understanding the intricate mechanisms driving CRC pathogenesis is essential for developing effective therapeutic strategies that can improve patient outcomes.  \nCentral to CRC pathogenesis are driver mutations in key oncogenes and tumor suppressor genes, which orchestrate dysregulated cellular pathways pivotal in tumorigenesis [4, 5]. Among the most frequently mutated genes in CRC are adenomatous polyposis coli (APC), Kirsten rat sarcoma viral oncogene homolog (KRAS), TP53 (tumor protein p53), BRAF (v-Raf murine sarcoma viral oncogene homolog B) and other novel driver genes  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under ","cbCaif15LdTb7C0H","https://ap.wps.com/l/cbCaif15LdTb7C0H","pdf",1220937,18,"English","# Abstract\n# Introduction\n## Colorectal cancer as a global health challenge\n## Role of driver mutations in CRC pathogenesis\n## Oxidative stress, ROS imbalance, and dual functions\n## Oxidative stress as a driver and modulator of therapy responses","[{\"question\":\"How do driver mutations contribute to colorectal cancer development?\",\"answer\":\"Driver mutations initiate and advance CRC by altering key signaling pathways that regulate cell proliferation, apoptosis, and genomic stability. These changes support tumor growth and therapeutic resistance.\"},{\"question\":\"What is oxidative stress and why is it important in CRC?\",\"answer\":\"Oxidative stress results from an imbalance between ROS production and antioxidant defenses. It promotes DNA damage, lipid peroxidation, and redox signaling dysregulation, influencing CRC pathogenesis.\"},{\"question\":\"How does oxidative stress interact with therapeutic responses in CRC?\",\"answer\":\"Oxidative stress can act as both a tumorigenic factor and a modulator of therapeutic responses. ROS-induced damage and altered redox signaling can affect treatment outcomes and resistance mechanisms.\"}]","The interplay between driver mutation and oxidative stress in colorectal cancer: from pathogenesis to therapeutics | PDF",1790183482,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f46368f6c6bbe87ba55b9825d2ba091b.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df6219dacbd87356f8e6372a9cbe64ee.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38b21011921a871163f19abc22ac42b3.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/676b9775c7f2d64303894474dfa16390.webp",980,1301]